Alzheimer's tau imaging breakthrough promises earlier diagnosis

A large University of Pittsburgh study compared two PET tracers for tau protein, the standard Flortaucipir and the newer MK6240, in 775 participants. MK6240 consistently identified more tau pathology, detecting over twice as many tau‑positive cases among people with amyloid buildup but no cognitive symptoms and showing higher sensitivity across all disease stages. Researchers say the improved detection could allow clinicians to diagnose Alzheimer’s earlier and better target emerging therapies.

Separately, Columbia University scientists uncovered a molecular mechanism that initiates tau filament formation. By disabling a neuronal disposal system called the neuroproteasome, they triggered rapid tau misfolding that mirrors patient‑derived tangles. The effect was amplified in brains carrying the high‑risk APOE4 variant and diminished in APOE2 carriers, linking genotype and aging to tau pathology. The findings suggest new therapeutic targets to stop tau tangles before they cause neurodegeneration.